» Articles » PMID: 21720761

PI3 Kinase Regulation of Neural Regeneration and Muscle Hypertrophy After Spinal Cord Injury

Overview
Journal Mol Biol Rep
Specialty Molecular Biology
Date 2011 Jul 2
PMID 21720761
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Spinal cord injury (SCI) is a serious neurotrauma that can lead to life-long disability; to date, no suitable therapeutic strategy exists. Axons do not regenerate after SCI in adult mammals and loss of skeletal muscle mass occurs very rapidly after SCI. Promotion of neurite growth through improving the extracellular environment allows only a limited degree of axon regeneration. The phosphatidylinositol-3 kinase (PI3K)/Akt pathway and its downstream targets ("mammalian target of rapamycin," mTOR, and glycogen synthase kinase-3), which regulate cell growth and proliferation in many tissues, have been suggested to play an important role in regulation of the intrinsic axonal regeneration and muscle hypertrophy. This review is focused on recent progress in our understanding of the PI3K pathway in the modulation of axonal regeneration and muscle hypertrophy after SCI.

Citing Articles

The relevance of BDNF for neuroprotection and neuroplasticity in multiple sclerosis.

Maiworm M Front Neurol. 2024; 15:1385042.

PMID: 39148705 PMC: 11325594. DOI: 10.3389/fneur.2024.1385042.


Nrf2 Signaling Pathway: Focus on Oxidative Stress in Spinal Cord Injury.

Xiao C, Lai H, Zhou J, Liu W, Zhao M, Zhao K Mol Neurobiol. 2024; 62(2):2230-2249.

PMID: 39093381 DOI: 10.1007/s12035-024-04394-z.


Targeting PI3K/Akt in Cerebral Ischemia Reperfusion Injury Alleviation: From Signaling Networks to Targeted Therapy.

Zheng T, Jiang T, Ma H, Zhu Y, Wang M Mol Neurobiol. 2024; 61(10):7930-7949.

PMID: 38441860 DOI: 10.1007/s12035-024-04039-1.


PKN1 Exerts Neurodegenerative Effects in an In Vitro Model of Cerebellar Hypoxic-Ischemic Encephalopathy via Inhibition of AKT/GSK3β Signaling.

Zur Nedden S, Safari M, Fresser F, Faserl K, Lindner H, Sarg B Biomolecules. 2023; 13(11.

PMID: 38002281 PMC: 10669522. DOI: 10.3390/biom13111599.


Targeting NF-κB in Hepatic Ischemia-Reperfusion Alleviation: from Signaling Networks to Therapeutic Targeting.

Deng R, Zhou J Mol Neurobiol. 2023; 61(6):3409-3426.

PMID: 37991700 DOI: 10.1007/s12035-023-03787-w.


References
1.
Fingar D, Blenis J . Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene. 2004; 23(18):3151-71. DOI: 10.1038/sj.onc.1207542. View

2.
Leger B, Vergani L, Soraru G, Hespel P, Derave W, Gobelet C . Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin-1. FASEB J. 2006; 20(3):583-5. DOI: 10.1096/fj.05-5249fje. View

3.
Kim W, Zhou F, Zhou J, Yokota Y, Wang Y, Yoshimura T . Essential roles for GSK-3s and GSK-3-primed substrates in neurotrophin-induced and hippocampal axon growth. Neuron. 2006; 52(6):981-96. PMC: 4167845. DOI: 10.1016/j.neuron.2006.10.031. View

4.
Coghlan M, Culbert A, Cross D, Corcoran S, YATES J, Pearce N . Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Chem Biol. 2000; 7(10):793-803. DOI: 10.1016/s1074-5521(00)00025-9. View

5.
Rommel C, Bodine S, Clarke B, Rossman R, Nunez L, Stitt T . Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat Cell Biol. 2001; 3(11):1009-13. DOI: 10.1038/ncb1101-1009. View